Christopher K. Murray, SVP, TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 5,000 shares at $65.00 ($314K) on 2022-08-05, disclosed to the SEC on 2022-08-08.
Open-market sale of $314k BPMC by SVP, TECHNICAL OPERATIONS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.44 | 2,500 | $151K | 48.2% |
| 2 | $65.00 | 2,500 | $163K | 51.8% |
| Total | $62.72 avg | 5,000 | $314K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-01 | $500K | — | Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |